Work

Down syndrome and Alzheimer's disease: insights into biomarkers, clinical symptoms, and pathology

Year: 2025

Type: review

Source: The Lancet Neurology

DOI: 10.1016/s1474-4422(25)00237-6

Authors: Michael S Rafii, Zinayida Schlachetzki, Isabel Barroeta, Elizabeth Head, Juan Fortea, Beau M Ances

Institutions: University of Southern California, Universitat Autònoma de Barcelona, Hospital de Sant Pau, University of California, Irvine, Washington University in St. Louis

Language: English

Topic: Down syndrome and intellectual disability research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institute on Aging, Eunice Kennedy Shriver National Institute of Child Health and Human Development

Awards: Neurodegeneration in Aging Down Syndrome (NiAD): A Longitudinal Study of Cognition and Biomarkers of Alzheimer's Disease, Clinical trials to prevent Alzheimer's Disease in Down Syndrome, Biomarkers of Alzheimer's Disease in Adults with Down Syndrome

OpenAlex ID: W4413150249

FWCI: 7.033

Cites: 88

Cited by: 37

Related to: 10